OBN Co-Founds and Subscribes to EDCA
News Feb 05, 2013
OBN has announced its co-founding and support of the European Diagnostic Clusters Alliance (EDCA). This significant step has been taken in support of OBN’s Diagnostic Member Companies.
OBN believes that the first European world class diagnostic cluster has now become a reality through the creation of the EDCA an international non-for-profit organization, headquartered in Brussels.
Through this Alliance, OBN will help to foster and develop collaborative networking between the other allied European diagnostic clusters in order to consolidate the competitiveness of their SMEs.
Access to non-EU markets (USA and Asia) for European medical diagnostic SMEs is also a key objective to the EDCA members.
OBN has been increasing its activity in support of SME diagnostics businesses in the UK in recent years, with last October’s very popular BioTuesday event “Meet with AstraZeneca's Head of Personalized Healthcare & Biomarkers and Biomarker company showcase.”
What does this mean for OBN diagnostics Members? They will gain access to sources of information on potential collaborators, join in grant applications for European funding and have the opportunity to network with European colleagues and potential partners.
EDCA members participated in OBN’s BioTrinity 2012, Europe’s premier biopartnering and investment conference and it is hoped that OBN will lead a party of OBN Diagnostics company members to the forthcoming Euromediag International Convention in Montpelier in July.
OBN’s involvement includes Advisory Board Member Bruce Savage as treasurer and lead contact.
Dr Jon Rees, CEO of OBN, said: “I am delighted that OBN is a member of the EDCA, this demonstrates our ongoing engagement with Medical Technology companies, membership of the EDCA will strengthen our offering to member companies and will give them opportunities to collaborate and partner with organizations throughout Europe and beyond. Redoubling our commitment to this sector, OBN is now planning towards a new medtech and diagnostics investing and partnering conference.”
New Rapid Test for Valley Fever Should Help Reduce Diagnosis DelaysNews
November saw a spike if cases of Valley fever. Fortunately, the recent—and timely—approval of a new rapid assay test for Valley fever should reduce delays in diagnosing the respiratory fungal infections—a frequent problem in treating the disease, which is caused by spores endemic to soils in the U.S. Southwest.READ MORE
Blood Sample Detection Method for Multiple Sclerosis DiscoveredNews
A method for quickly detecting signs of multiple sclerosis has been developed by a University of Huddersfield research team. The process will avoid the invasive, painful process of collecting fluid from the brain and spineREAD MORE
Faster, More Accurate Cancer Detection Using NanoparticlesNews
Using light-emitting nanoparticles, Rutgers University-New Brunswick scientists have invented a highly effective method to detect tiny tumors and track their spread, potentially leading to earlier cancer detection and more precise treatment.READ MORE